David C Hastings - Net Worth and Insider Trading
David C Hastings Net Worth
The estimated net worth of David C Hastings is at least $934,496 dollars as of 2024-04-26. David C Hastings is the CFO of Arbutus Biopharma Corp and owns about 181,907 shares of Arbutus Biopharma Corp (ABUS) stock worth over $494,787. David C Hastings is the CFO of Incyte Corp and owns about 8,500 shares of Incyte Corp (INCY) stock worth over $435,030. David C Hastings is also the Director of SCYNEXIS Inc and owns about 3,183 shares of SCYNEXIS Inc (SCYX) stock worth over $4,679. Details can be seen in David C Hastings's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David C Hastings has not made any transactions after 2024-02-02 and currently still holds the listed stock(s).
Transaction Summary of David C Hastings
David C Hastings Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David C Hastings owns 6 companies in total, including SCYNEXIS Inc (SCYX) , Entasis Therapeutics Holdings Inc (ETTX) , and Arbutus Biopharma Corp (ABUS) among others .
Click here to see the complete history of David C Hastings’s form 4 insider trades.
Insider Ownership Summary of David C Hastings
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SCYX | SCYNEXIS Inc | 2023-06-15 | director |
ETTX | Entasis Therapeutics Holdings Inc | 2019-06-19 | director |
ABUS | Arbutus Biopharma Corp | 2024-02-02 | Chief Financial Officer |
UNISQ | Unilife Corp | 2017-01-26 | See Remarks |
INCY | Incyte Corp | 2014-06-05 | Exec VP & CFO |
VBLT | Vascular Biogenics Ltd | 2023-01-01 | director |
David C Hastings Latest Holdings Summary
David C Hastings currently owns a total of 3 stocks. Among these stocks, David C Hastings owns 181,907 shares of Arbutus Biopharma Corp (ABUS) as of February 2, 2024, with a value of $494,787 and a weighting of 52.95%. David C Hastings owns 8,500 shares of Incyte Corp (INCY) as of June 5, 2014, with a value of $435,030 and a weighting of 46.55%. David C Hastings also owns 3,183 shares of SCYNEXIS Inc (SCYX) as of March 8, 2018, with a value of $4,679 and a weighting of 0.5%.
Latest Holdings of David C Hastings
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABUS | Arbutus Biopharma Corp | 2024-02-02 | 181,907 | 2.72 | 494,787 |
INCY | Incyte Corp | 2014-06-05 | 8,500 | 51.18 | 435,030 |
SCYX | SCYNEXIS Inc | 2018-03-08 | 3,183 | 1.47 | 4,679 |
Holding Weightings of David C Hastings
David C Hastings Form 4 Trading Tracker
According to the SEC Form 4 filings, David C Hastings has made a total of 1 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 9,593 shares on February 2, 2024, which brought David C Hastings around $22,160.
According to the SEC Form 4 filings, David C Hastings has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 200,000 shares on June 5, 2014, which brought David C Hastings around $11 Million.
According to the SEC Form 4 filings, David C Hastings has made a total of 0 transactions in SCYNEXIS Inc (SCYX) over the past 5 years. The most-recent trade in SCYNEXIS Inc is the acquisition of 1,183 shares on March 8, 2018, which cost David C Hastings around $20,000.
Insider Trading History of David C Hastings
- 1
David C Hastings Trading Performance
GuruFocus tracks the stock performance after each of David C Hastings's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David C Hastings is 27.38%. GuruFocus also compares David C Hastings's trading performance to market benchmark return within the same time period. The performance of stocks bought by David C Hastings within 3 months outperforms 5 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David C Hastings's insider trading performs compared to the benchmark.
Performance of David C Hastings
Average Return
70.06%
Outperforming Transactions
60%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 16.14 | 27.38 | 22.07 | 70.06 | 48.46 | 9.6 |
Relative Return to S&P 500(%) | 11.67 | 24.17 | 9.88 | 50.31 | 36.83 | 1.58 |
David C Hastings Ownership Network
Ownership Network List of David C Hastings
Ownership Network Relation of David C Hastings
David C Hastings Owned Company Details
What does SCYNEXIS Inc do?
Who are the key executives at SCYNEXIS Inc?
David C Hastings is the director of SCYNEXIS Inc. Other key executives at SCYNEXIS Inc include Chief Financial Officer Ivor Macleod , General Counsel Scott Sukenick , and Interim CFO Lawrence R Hoffman .
SCYNEXIS Inc (SCYX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.
SCYNEXIS Inc Insider Transactions
David C Hastings Mailing Address
Above is the net worth, insider trading, and ownership report for David C Hastings. You might contact David C Hastings via mailing address: C/o Arbutus Biopharma, 100-8900 Glenlyon Parkway, Burnaby A1 V5j 5j8.